MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-04-0048839
Grassindia Pharmaceuticals Private Limited
Grassindia Pharmaceuticals Private Limited - pharma in Aurangabad, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹23.14 Lakh
▼ 96% YoY
Net loss · FY 2025
₹64,964
Net margin -2.8%
EBITDA · FY 2025
₹1.91 Lakh
EBITDA margin 8.3%
Authorised capital
₹20 Lakh
Registered with MCA
Paid-up capital
₹20 Lakh
Issued & subscribed
Company age
7 yrs
Est. 2019
Directors on board
2
As per MCA filings
Active GSTINs
2
GST registered
About Grassindia Pharmaceuticals Private Limited
Data last updated:
Grassindia Pharmaceuticals Private Limited is a private limited company based in Aurangabad, Maharashtra, India. It operates in the animal pharmaceuticals and healthcare segment of the pharmaceuticals sector. It was incorporated on 02 July 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24304MH2019PTC327515. Its GSTIN is 27AAHCG8905A1ZR (Maharashtra). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹20 Lakh and a paid-up capital of ₹20 Lakh. It is led by directors Pankaj Thaware and Yogesh Gaikwad.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Mhalgaon Tq.Vaijapur, Aurangabad, Maharashtra, India – 423701.
As per the financials filed for FY 2025, the company reported a revenue of ₹23.14 Lakh, a decline of 96% compared to the previous year. For the same year it recorded a net loss of ₹64,964 (net margin -2.8%) and EBITDA of ₹1.91 Lakh (EBITDA margin 8.3%). Revenue has grown at a compounded annual rate (CAGR) of 27% over three years and 18% over five years.
Grassindia Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-04-0048839).
Company details
CIN U24304MH2019PTC327515
Registration Number 327515
Incorporation Date 02 July 2019
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
MSME Classification Micro
Udyam Registration UDYAM-MH-04-0048839
Key People
Pankaj Thaware Director Yogesh Gaikwad Director Recognitions & Rankings of Grassindia Pharmaceuticals
Contact details
Grassindia Pharmaceuticals Private Limited's registered office is in Aurangabad, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressMhalgaon Tq.Vaijapur, Aurangabad, Maharashtra, India – 423701
- IndustryPharma, Animal Pharmaceuticals & Healthcare
To see the full contact details of Grassindia Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Grassindia Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Grassindia Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Grassindia Pharmaceuticals Private Limited, buy the company report.
Financials of Grassindia Pharmaceuticals Private Limited
FY 2024 filings availableGrassindia Pharmaceuticals Private Limited reported revenue of ₹23.14 Lakh (down 96% YoY) for FY 2025.
Revenue · FY 2025
₹23.14 Lakh ▼ 96%
Net loss · FY 2025
₹64,964 margin -2.8%
EBITDA · FY 2025
₹1.91 Lakh margin 8.3%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 96%
3 years · compounded
▼ 27%
5 years · compounded
▲ 18%
EBITDA CAGR growth
1 year
▼ 100%
3 years · compounded
▲ 1%
5 years · compounded
▲ 10%
Revenue fell 96% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 18%. EBITDA fell 100% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.91 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹64,964 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 8.3% | ||||
| Net Profit Margin | -2.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Grassindia Pharmaceuticals Private Limited, buy the company report.
Board of directors of Grassindia Pharmaceuticals Private Limited
Grassindia Pharmaceuticals has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pankaj Thaware | Director | 02 Jul 2019 | 7 Years 3 Months | Current |
| Yogesh Gaikwad | Director | 02 Jul 2019 | 7 Years 3 Months | Current |
Peer comparison
Grassindia Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Animal Pharma, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Uencure Pharmaceuticals Private Limited | ₹23.34 Lakh (FY 2021) | 104.0% | Po Kala Amb, Tehsil Nahan, Himachal Pradesh, India | |||
| Philbert Pharmaceuticals Private Limited | ₹23.16 Lakh (FY 2025) | -9.0% | Surat, Gujarat, India | |||
| Grassindia Pharmaceuticals Private Limitedthis company | ₹23.14 Lakh (FY 2025) | -₹64,964 | -2.8% | -96.0% | Aurangabad, Maharashtra, India | |
| Airmed Pharmaceuticals (India) Private Limited | ₹23.09 Lakh (FY 2020) | -47.0% | Hyderabad, Telangana, India | |||
| Argor Pharmaceuticals Private Limited | ₹23 Lakh (FY 2024) | 73.0% | Chennai, Tamil Nadu, India |
To see the full peer comparison of Grassindia Pharmaceuticals Private Limited, buy the company report.
Auditor
Grassindia Pharmaceuticals Private Limited is audited by SUYOGMAHAVIRPANDE for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SUYOGMAHAVIRPANDE | FY 2022 | 176510 |
Shareholding
The shareholding of Grassindia Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Grassindia Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Grassindia Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Grassindia Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Grassindia Pharmaceuticals has 2 GST registrations: 2 active.
Total GSTINs
2
Active
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAHCG8905A1ZR | Maharashtra | Active | 27 Sep 2019 |
| 27AAFCE5148K1ZD | Maharashtra | Active | 13 Aug 2024 |
To see the full GST registrations and return filing status of Grassindia Pharmaceuticals Private Limited, buy the company report.
Recent activity
Grassindia Pharmaceuticals Private Limited has 2 board changes on record since 2019: 2 appointments. The latest: Pankaj Thaware was appointed as Director on 02 Jul 2019.
AGM
Grassindia Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Grassindia Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
Appointed
Pankaj Thaware was appointed as Director.
Appointed
Yogesh Gaikwad was appointed as Director.
Incorporation
02 Jul 2019
Grassindia Pharmaceuticals Private Limited was registered on 02 Jul 2019 with Roc Mumbai & aged 7 years 4 months as per MCA records.
Frequently asked questions
Grassindia Pharmaceuticals is an active private limited company based in Aurangabad, Maharashtra, India. The company works in animal pharmaceuticals and healthcare, within the pharma industry. It was incorporated on 02 July 2019 (7+ years old) and is registered under CIN U24304MH2019PTC327515.
Grassindia Pharmaceuticals has 2 current directors:
- Pankaj Thaware - Director
- Yogesh Gaikwad - Director
The latest financial statements of Grassindia Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Grassindia Pharmaceuticals is 27AAHCG8905A1ZR, registered in Maharashtra. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 27AAFCE5148K1ZD (Maharashtra).
The CIN (Corporate Identification Number) of Grassindia Pharmaceuticals is U24304MH2019PTC327515. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Grassindia Pharmaceuticals was incorporated on 02 July 2019, making it 7+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Grassindia Pharmaceuticals by revenue are Uencure Pharmaceuticals Private Limited, Philbert Pharmaceuticals Private Limited, Airmed Pharmaceuticals (India) Private Limited, Argor Pharmaceuticals Private Limited, all in the Pharma industry (Animal Pharma, Pharmaceuticals), with the same principal business activity (wholesale trading).
Pankaj Thaware was appointed as Director on 02 Jul 2019. Yogesh Gaikwad was appointed as Director on 02 Jul 2019.
Yes, Grassindia Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-04-0048839).
The registered office of Grassindia Pharmaceuticals is at Mhalgaon Tq.Vaijapur, Aurangabad, Maharashtra, India – 423701.
Grassindia Pharmaceuticals operates in the pharma industry, in the animal pharmaceuticals and healthcare segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages